EQUITY AWARDS (Tables)

12 Months Ended

Dec. 31, 2020

Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]

Schedule of Valuation Assumptions

The fair value of options granted was determined using the following weighted-average assumptions as of grant date, for the years ended December 31:

	2020			2019			2018
Risk-free interest rate		0.79	%		2.11	%		2.87	%
Expected term (in years)		6.50			6.50			6.50
Expected stock price volatility		22.26	%		19.89	%		20.10	%
Dividend yield		2.56	%		2.36	%		1.76	%

Schedule of Stock Option Activity

A summary of activity in the Plan during the years ended December 31 follows:

2020	Number of Shares			Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Life in Years		Aggregate Intrinsic Value
Outstanding at beginning of year		508,000		$	26.68		6.24	$	3,159
Granted		74,000			28.67		9.57		145
Exercised		(26,600	)		24.00		1.79		158
Forfeited		(49,200	)		29.71		7.58		84
Balance, December 31, 2020		506,200		$	26.81		5.82	$	1,805
Exercisable at end of period		291,520		$	25.63		4.74	$	1,339

2019	Number of Shares			Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Life in Years		Aggregate Intrinsic Value
Outstanding at beginning of year		537,872		$	26.49		6.97	$	2,088
Granted		39,000			29.89		9.40		117
Exercised		(37,672	)		24.55		4.11		314
Forfeited		(31,200	)		30.04		8.02		89
Balance, December 31, 2019		508,000		$	26.68		6.24	$	3,159
Exercisable at end of period		256,880		$	25.21		5.18	$	1,971

Schedule of Nonvested Stock Option Activity

A summary of nonvested activity in the Plan during the years ended December 31 follows:

2020	Number of Shares			Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Life in Years		Aggregate Intrinsic Value
Outstanding at beginning of year		251,120		$	28.18		7.31	$	1,188
Granted		74,000			28.67		9.57		145
Vested		(71,040	)		27.26		6.00		230
Forfeited		(39,400	)		29.71		7.58		84
Balance, December 31, 2020		214,680		$	28.42		7.28	$	466

2019	Number of Shares			Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Life in Years		Aggregate Intrinsic Value
Outstanding at beginning of year		331,560		$	27.74		7.77	$	975
Granted		39,000			29.89		9.40		117
Vested		(91,040	)		26.71		6.02		563
Forfeited		(28,400	)		33.00		8.81		89
Balance, December 31, 2019		251,120		$	28.18		7.31	$	1,188

Plan Information

Information related to the Plan is as follows for the years ended December 31:

	2020		2019		2018
Intrinsic value of options exercised	$	158	$	314	$	102
Cash received from options exercised		638		925		327
Weighted average fair value of options granted		4.46		4.97		6.69

Summary of Restricted Stock Activity

A summary of restricted stock activity in the Plan during the years ended December 31, 2020 and 2019 follows:

2020	Number of Shares			Weighted-Average Grant Date Fair Value
Outstanding at beginning of year		31,459		$	30.29
Granted		19,500			29.32
Vested		(15,179	)		30.33
Forfeited		(480	)		31.57
Balance, December 31, 2020		35,300		$	29.72

2019	Number of Shares			Weighted-Average Grant Date Fair Value
Outstanding at beginning of year		2,398		$	31.57
Granted		30,500			30.25
Vested		(1,439	)		31.57
Forfeited		—			—
Balance, December 31, 2019		31,459		$	30.29